The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Preclinical Imaging & Testing

The Preclinical Imaging & Testing Facility provides training and access to instrumentation for in vivo, whole animal imaging, including:

  • Bioluminescence and fluorescence imaging
  • Ultrasound and photoacoustic imaging
  • Magnetic resonance imaging (MRI)
  • Positron emission tomography (PET)
  • X-ray micro-computerized tomography (microCT)

In addition, the Facility provides assistance with design, approval, and execution of pilot studies and preclinical trials, to assist and accelerate the process of moving scientific breakthroughs from the research bench to the clinic. Our goal is to support and encourage translational efforts using refined animal models of disease to test:

  • Chemotherapeutic response and drug resistance
  • Biosensors for tumor detection and monitoring
  • Diagnostic assays
  • Cancer vaccines
  • Drug delivery systems and tumor-targeted modalities

Access is available to all members of the MIT community, to the extent permitted by available capacity. Priority access is given to KI members and NCI-funded research projects in recognition of funding support.  In special circumstances, access may be available to non-MIT users (details available on request from Facility Scientific Director Virginia Spanoudaki).

Facility Sponsors

National Cancer Institute Cancer Center